PTC to acquire BLA-stage ST-920 Fabry disease programme

Graviton BioScience's Investigational New Drug (IND) application for GV101 cleared for Friedreich's ataxia treatment

Galvanize Therapeutics' new Aliya EX System completes first commercial procedures

EIT Pharma's lonafarnib New Drug Application accepted for review by US FDA for chronic hepatitis D treatment

Lupin's Sodium Zirconium Cyclosilicate for Oral Suspension approved by US FDA

Labcorp receives FDA approval for melanoma companion diagnostic

Sobi partners with Innate Pharma to advance lacutamab in T-cell lymphoma

Oculis signs agreement to acquire Privosegtor from Accure Therapeutics

Biophytis receives Brazilian approval for Phase 2 obesity trial of BIO101

ImmuPharma selects Kymos Group as bioanalytical partner for Kapiglucagon

BioInvent receives FDA Fast Track designation for BI-1808 in ovarian cancer

Galibra Neuroscience's SSADH deficiency gene therapy receives FDA Orphan Drug and Rare Pediatric Disease Designations

Obsidian Therapeutics advances Agni-01 study with first patient enrolled in registration-enabling cohort

CVS Health expands GLP-1 weight management access through integrated care offering

Adyen to provide LillyDirect with payment technology services